Trial intelligence / Profile preview

M-PART in Head and Neck Cancer Patients Treated With KeraStat Cream for Acute Radiation Dermatitis

NCT06441266Completed

Sponsor
Wake Forest University Health Sciences
Start
May 2025
Primary completion
Jun 2026
Countries
1
01

Overview

Open-label, single-arm trial, sponsored by Wake Forest University Health Sciences. Primary endpoint: Number of Participants that Complete Scheduled Study Assessments to Measure for Feasibility up to 2 years. Started May 2025; status: completed.

Beyond the preview

Go deeper on NCT06441266.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06441266.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call